LEADER 00920nam0-22003131i-450- 001 990003042350403321 010 $a0-691-0392-0 035 $a000304235 035 $aFED01000304235 035 $a(Aleph)000304235FED01 035 $a000304235 100 $a20000920d1992----km-y0itay50------ba 101 0 $aeng 102 $aIT 200 1 $aCycles and Chaos in Economic Equilibrium$fEdited by Jess Benhabib 210 $aPrinceton (N.Y.)$cPrinceton University Press$d1992 215 $aVIII, 474 p.$d22 cm 610 0 $aCicli economici$aModelli matematici 610 0 $aEquilibrio economico$aModelli matematici 676 $aF/5 702 1$aBenhabib,$bJess 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003042350403321 952 $aF/5 BEN$b14677$fSES 952 $aF/5 BE/1$b14869$fSES 959 $aSES 996 $aCycles and Chaos in Economic Equilibrium$9463214 997 $aUNINA LEADER 06564nam 2200805 a 450 001 9910961795903321 005 20251116140717.0 010 $a9786610193219 010 $a9780309176699 010 $a0309176697 010 $a9781280193217 010 $a1280193212 010 $a9780309587648 010 $a0309587646 010 $a9780585023922 010 $a0585023921 035 $a(CKB)110986584751546 035 $a(EBL)3376097 035 $a(SSID)ssj0000184260 035 $a(PQKBManifestationID)11171861 035 $a(PQKBTitleCode)TC0000184260 035 $a(PQKBWorkID)10200361 035 $a(PQKB)10417306 035 $a(MiAaPQ)EBC3376097 035 $a(Au-PeEL)EBL3376097 035 $a(CaPaEBR)ebr10055091 035 $a(CaONFJC)MIL19321 035 $a(OCoLC)923260981 035 $a(Perlego)4735491 035 $a(BIP)1847331 035 $a(EXLCZ)99110986584751546 100 $a19941219d1995 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aIsotopes for medicine and the life sciences /$fCommittee on Biomedical Isotopes, Division of Health Sciences Policy, Institute of Medicine ; S. James Adelstein and Frederick J. Manning, editors 205 $a1st ed. 210 $aWashington, D.C. $cNational Academy Press$d1995 215 $a1 online resource (x, 132 pages) $cillustrations, map 300 $aDescription based upon print version of record. 311 08$a9780309051903 311 08$a0309051908 320 $aIncludes bibliographical references. 327 $a""Isotopes for Medicine and the Life Sciences""; ""Copyright""; ""Preface""; ""Contents""; ""Executive Summary""; ""ENRICHED STABLE ISOTOPES""; ""REACTOR-PRODUCED RADIONUCLIDES""; ""ACCELERATOR-PRODUCED RADIONUCLIDES""; ""PUBLIC-PRIVATE PARTNERSHIP MODELS FOR NBTF""; ""A NATIONAL ISOTOPE POLICY""; ""1 Introduction""; ""CHARGE TO THE COMMITTEE""; ""PLAN OF THE REPORT""; ""REFERENCES""; ""2 Enriched Stable Isotopes""; ""HISTORICAL PERSPECTIVE""; ""CURRENT APPLICATIONS IN MEDICINE AND PHYSICAL AND LIFE SCIENCES""; ""ISOTOPE SEPARATION IN THE UNITED STATES""; ""FUTURE SUPPLIES"" 327 $a""NEW AND ALTERNATIVE SEPARATION TECHNOLOGIES""""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""3 Reactor-Produced Radionuclides""; ""HISTORICAL PERSPECTIVE""; ""CURRENT APPLICATIONS IN MEDICINE AND PHYSICAL AND LIFE SCIENCES""; ""SUPPLIES AND SUPPLIERS""; ""Molybdenum-99""; ""Current Sources""; ""Future Sources""; ""Research and Development on Alternative Sources""; ""Other Commercial Radionuclides""; ""Research Radionuclides""; ""Market Analyses""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""4 Accelerator-Produced Radionuclides and a National BiomedicalTracer Facility"" 327 $a""HISTORICAL PERSPECTIVE""""CURRENT APPLICATIONS IN MEDICINE AND PHYSICAL AND LIFE SCIENCES""; ""SUPPLIES AND SUPPLIERS""; ""Commercially Available Radioisotopes""; ""Short-Lived Radioisotopes for PET""; ""Radionuclides Currently Produced at DOE Facilities""; ""BLIP""; ""LAMPF""; ""TRIUMF""; ""Future Production""; ""Proposed NBTF""; ""Upgraded BLIP""; ""In-House Research and Education at the NBTF""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""5 Public-Private Partnership Models for NBTF""; ""THE DOE ISOTOPE PRODUCTION AND DISTRIBUTION PROGRAM""; ""CANADA'S TRIUMF"" 327 $a""NORDION AND ISOTOPES""""UNIVERSITIES AND NATIONAL LABORATORIES IN RESEARCH""; ""DOE LABORATORY AND UNIVERSITY PARTNERSHIPS WITH COMMERCIAL VENTURES""; ""Radiation Therapy at Brookhaven""; ""Continuous Electron Beam Accelerator Facility (CEBAF)""; ""Technology Transfer and Cooperative Agreements""; ""POSSIBLE MODEL FOR NBTF""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""6 A National Isotope Policy: Proposal for a New Way to Manage the Nation's Isotope Resources""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""APPENDIXES""; ""APPENDIX A Waste Management"" 327 $a""NATURE AND SOURCES OF LOW-LEVEL RADIOACTIVE WASTE (LLRW)""""RISK FROM LLRW""; ""DISPOSAL SITES""; ""IMPLICATIONS FOR ISOTOPE PRODUCTION AND USE""; ""REFERENCES""; ""APPENDIX B Legal Considerations""; ""THE ATOMIC ENERGY ACT OF 1954""; ""PUBLIC LAW 101-101""; ""THE TECHNOLOGY TRANSFER ACT OF 1986""; ""ANTI-TRUST CONSIDERATIONS""; ""REFERENCES""; ""APPENDIX C Acronyms and Abbreviations""; ""APPENDIX D Table of Elements""; ""APPENDIX E Glossary"" 330 $aRadioactive isotopes and enriched stable isotopes are used widely in medicine, agriculture, industry, and science, where their application allows us to perform many tasks more accurately, more simply, less expensively, and more quickly than would otherwise be possible. Indeed, in many cases--for example, biological tracers--there is no alternative. In a stellar example of "technology transfer" that began before the term was popular, the Department of Energy (DOE) and its predecessors has supported the development and application of isotopes and their transfer to the private sector. The DOE is now at an important crossroads: Isotope production has suffered as support for DOE's laboratories has declined. In response to a DOE request, this book is an intensive examination of isotope production and availability, including the education and training of those who will be needed to sustain the flow of radioactive and stable materials from their sources to the laboratories and medical care facilities in which they are used. Chapters include an examination of enriched stable isotopes; reactor and accelerator-produced radionuclides; partnerships among industries, national laboratories, and universities; and national isotope policy. 606 $aRadioisotopes in medical diagnosis$zUnited States 606 $aRadioisotopes$xTherapeutic use$zUnited States 606 $aLife sciences$xResearch$zUnited States 606 $aRadioisotopes in research$zUnited States 615 0$aRadioisotopes in medical diagnosis 615 0$aRadioisotopes$xTherapeutic use 615 0$aLife sciences$xResearch 615 0$aRadioisotopes in research 676 $a616.07/575 701 $aAdelstein$b S. J$01813931 701 $aManning$b Frederick J$01806438 712 02$aInstitute of Medicine (U.S.).$bCommittee on Biomedical Isotopes. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910961795903321 996 $aIsotopes for medicine and the life sciences$94367454 997 $aUNINA